1. Home
  2. DFNS vs AEMD Comparison

DFNS vs AEMD Comparison

Compare DFNS & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo T3 Defense Inc. Common Stock

DFNS

T3 Defense Inc. Common Stock

N/A

Current Price

$1.98

Market Cap

4.2M

ML Signal

N/A

Logo Aethlon Medical Inc.

AEMD

Aethlon Medical Inc.

N/A

Current Price

$5.47

Market Cap

3.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DFNS
AEMD
Founded
2013
1984
Country
United States
United States
Employees
N/A
9
Industry
Professional Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
3.9M
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
DFNS
AEMD
Price
$1.98
$5.47
Analyst Decision
Hold
Analyst Count
0
2
Target Price
★ $65.00
$13.25
AVG Volume (30 Days)
★ 479.6K
54.1K
Earning Date
11-17-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 261.46
N/A
EPS
N/A
★ N/A
Revenue
★ $5,913,461.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$33.09
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.82
$0.53
52 Week High
$335.00
$25.66

Technical Indicators

Market Signals
Indicator
DFNS
AEMD
Relative Strength Index (RSI) 22.59 52.35
Support Level N/A $4.86
Resistance Level $7.36 $6.69
Average True Range (ATR) 0.44 0.39
MACD 0.04 -0.03
Stochastic Oscillator 0.76 45.61

Price Performance

Historical Comparison
DFNS
AEMD

About DFNS T3 Defense Inc. Common Stock

T3 Defense Inc is a holding company that acquires and operates mission-critical defense businesses involved in national security programs. The company operates as a strategic platform, building a portfolio of mission-critical suppliers and technology companies. Its portfolio includes businesses involved in defense and aerospace technologies, such as AI software, unmanned aerial systems, electro-mechanical manufacturing, and motion control systems, as well as activities in technology distribution, licensing, and defense infrastructure development through joint ventures.

About AEMD Aethlon Medical Inc.

Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.

Share on Social Networks: